Simufilam 100 mg for Mild to Moderate Alzheimer’s Disease
- Alzheimer’s Disease
- **other criteria will apply
For more information, call Tatiana Jimenez-Knight at 716-961-9219 or email firstname.lastname@example.org. You can also visit: https://rethink-alz.com/
Want to participate in a study?
Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.